Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.79
+0.38 (2.06%)
At close: Mar 19, 2026, 4:00 PM EDT
18.35
-0.44 (-2.34%)
Pre-market: Mar 20, 2026, 6:12 AM EDT
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.03 billion as of March 20, 2026. Its market cap has increased by 27.13% in one year.
Market Cap
1.03B
Enterprise Value
741.16M
1-Year Change
27.13%
Ranking
Category
Stock Price
$18.79
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.03B, an increase of 10.48%. That is a compound annual growth rate of 6.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 1.22B | 32.40% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Septerna | 1.08B |
| Tevogen Bio Holdings | 1.08B |
| AbCellera Biologics | 1.07B |
| Pharming Group | 1.05B |
| Savara | 1.03B |
| ArriVent BioPharma | 1.01B |
| Inhibrx Biosciences | 999.01M |
| Geron | 992.84M |